X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
male (9) 9
middle aged (8) 8
index medicus (7) 7
oncology (7) 7
prostate cancer (7) 7
aged (6) 6
cancer (6) 6
hematology, oncology and palliative medicine (5) 5
aged, 80 and over (4) 4
analysis (4) 4
care and treatment (4) 4
clinical trials (4) 4
men (4) 4
quality of life (4) 4
adult (3) 3
carcinoma (3) 3
clinical medicine (3) 3
europe (3) 3
female (3) 3
outcomes (3) 3
prostatic neoplasms - psychology (3) 3
prostatic neoplasms - therapy (3) 3
radiotherapy (3) 3
research (3) 3
survival (3) 3
survivors (3) 3
urology & nephrology (3) 3
adenocarcinoma (2) 2
androgen antagonists - therapeutic use (2) 2
cancer and oncology (2) 2
cancer och onkologi (2) 2
cancer patients (2) 2
cancer therapies (2) 2
combined modality therapy (2) 2
cross-sectional studies (2) 2
disease-free survival (2) 2
health (2) 2
health aspects (2) 2
immunohistochemistry (2) 2
inventories (2) 2
klinisk medicin (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
multivariate analysis (2) 2
neoplasm staging (2) 2
norway (2) 2
nuclear radiation (2) 2
oncology, experimental (2) 2
pain (2) 2
prostatic neoplasms - radiotherapy (2) 2
surveys and questionnaires (2) 2
testicular cancer (2) 2
testicular neoplasms - psychology (2) 2
time factors (2) 2
treatment outcome (2) 2
acceptability (1) 1
adjuvant chemotherapy (1) 1
adolescent (1) 1
adverse effects (1) 1
african-american (1) 1
age (1) 1
androgen deprivation therapy (1) 1
androgen receptor (1) 1
androgens (1) 1
animal populations (1) 1
antigens (1) 1
antineoplastic agents, hormonal - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - adverse effects (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
artisanal fisheries (1) 1
assisted radical prostatectomy (1) 1
association patterns (1) 1
asylum, right of (1) 1
australia (1) 1
behavioral sciences (1) 1
biopsy, needle (1) 1
bladder cancer (1) 1
bone marrow (1) 1
bone neoplasms - radiotherapy (1) 1
bone neoplasms - secondary (1) 1
bottle-nosed dolphins (1) 1
bottlenose dolphin (1) 1
breast cancer (1) 1
breast-cancer (1) 1
canada (1) 1
cancer survivorship (1) 1
carcinoma - drug therapy (1) 1
carcinoma - mortality (1) 1
carcinoma - pathology (1) 1
carcinoma - surgery (1) 1
carcinoma, transitional cell - metabolism (1) 1
cells (1) 1
chemotherapy (1) 1
chemotherapy, adjuvant (1) 1
cisplatin - administration & dosage (1) 1
clinical trials, phase iii as topic - methods (1) 1
cohort studies (1) 1
colorectal cancer (1) 1
colorectal neoplasms (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 738 - 746
Journal Article
Lancet Oncology, ISSN 1470-2045, 2015, Volume 16, Issue 1, pp. 76 - 86
Summary Background Patients with muscle-invasive urothelial carcinoma of the bladder have poor survival after cystectomy. The EORTC 30994 trial aimed to... 
Hematology, Oncology and Palliative Medicine | ADJUVANT CHEMOTHERAPY | PLUS CISPLATIN | METAANALYSIS | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DOXORUBICIN | METHOTREXATE | VINBLASTINE | CANCER | GEMCITABINE | Lymph Node Excision | Cystectomy - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Male | Vinblastine - administration & dosage | Cystectomy - adverse effects | Urothelium - pathology | Cisplatin - administration & dosage | Time Factors | Urinary Bladder Neoplasms - pathology | Female | Chemotherapy, Adjuvant | Carcinoma - pathology | Doxorubicin - administration & dosage | Carcinoma - drug therapy | Urinary Bladder Neoplasms - mortality | Drug Administration Schedule | Time-to-Treatment | Carcinoma - surgery | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Urinary Bladder Neoplasms - surgery | Canada | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Methotrexate - administration & dosage | Urothelium - surgery | Neoplasm Staging | Urothelium - drug effects | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Carcinoma | Hospitals | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2009, Volume 10, Issue 4, pp. 370 - 380
Journal Article
Journal Article
Health and Quality of Life Outcomes, ISSN 1477-7525, 05/2017, Volume 15, Issue 1, pp. 1 - 14
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 08/1999, Volume 36, Issue 2, pp. 163 - 163
Journal Article
European Urology, ISSN 0302-2838, 05/2000, Volume 37, Issue 5, pp. 541 - 551
Objectives: To compare the quality of life (QL) of patients with poor prognosis M1 prostate cancer treated with orchiectomy alone (ORCH) or orchiectomy... 
Prostate Cancer
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.